FIELD: medicine.
SUBSTANCE: method involves applying basic therapy until stroke type is unclear and differentiated therapy after having determined stroke type. Recombinant interleukine-2-roncoleukine as subcutaneous injections at a dose of 500 000 MU into external surface of intact arm at the fourth-fifth day after stroke beginning. Roncoleukine is administered as a course of 1-3 injections given with two-three days pause on the background of traditional stroke treatment.
EFFECT: enhanced effectiveness of treatment.
2 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ACUTE CEREBRAL CIRCULATION DISORDER COURSE FORECAST | 2007 |
|
RU2327994C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEMORRHAGIC AND ISCHEMIC INSULT | 2005 |
|
RU2287821C1 |
| METHOD OF PREDICTION OF ISCHEMIC STROKE COURSE | 2007 |
|
RU2324941C1 |
| METHOD OF CORRECTION OF IMMUNOLOGICAL DISORDERS IN THE ACUTE PERIOD OF ISCHEMIC STROKE | 2017 |
|
RU2661091C1 |
| METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
| METHOD FOR STROKE TREATMENT | 2014 |
|
RU2571282C1 |
| METHOD OF TREATING PATIENTS WITH ACUTE CARABROVASCULAR PATHOLOGY WITH UNDERLYING POSTTRAUMATIC STRES DISORDER ENSURED BY COMBINED PSYCHOPHARMACOLOGICAL THERAPY | 2010 |
|
RU2454235C2 |
| METHOD FOR PREDICTING THE RECOVERY OF FUNCTIONS IMPAIRED AS A RESULT OF CEREBRAL STROKE IN ELDERLY MEN | 2022 |
|
RU2781115C1 |
| METHOD FOR PREDICTING THE OUTCOME OF ISCHEMIC STROKE | 2018 |
|
RU2703474C1 |
| METHOD FOR EVALUATING ISCHEMIC STROKE SEVERITY DEGREE IN PEOPLE BEING NOT MORE THAN 50 YEARS OLD | 2005 |
|
RU2312356C2 |
